Evaluation of Guillain-Barre Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001

被引:43
作者
Burwen, Dale R. [1 ]
Ball, Robert [1 ]
Bryan, Wilson W. [2 ]
Izurieta, Hector S. [1 ]
La Voie, Lawrence [5 ,6 ]
Gibbs, Neville A. [2 ]
Kliman, Rebecca [3 ,4 ]
Braun, M. Miles [1 ]
机构
[1] US FDA, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA
[2] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[3] Ctr Medicare, Qual Improvement Grp, Off Clin Stand & Qual, Baltimore, MD USA
[4] Ctr Medicaid Serv, Qual Improvement Grp, Off Clin Stand & Qual, Baltimore, MD USA
[5] Ctr Medicare, Kansas City Reg Off, Kansas City, MO USA
[6] Ctr Medicare, Kansas City Reg Off, Kansas City, MO USA
关键词
UNITED-STATES; ASSOCIATION; IMMUNIZATION; SURVEILLANCE; FEATURES; CRITERIA; SAFETY; SWEDEN;
D O I
10.1016/j.amepre.2010.05.022
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The 1976-1977 swine influenza vaccine was associated with an elevated risk of Guillain-Barre Syndrome (GBS), especially within 6 weeks after vaccination. A 2004 IOM report concluded that evidence was inadequate to accept or reject a causal relationship between subsequent influenza vaccine formulations and GBS. Studies published after the IOM report have been limited by passively reported data or lack of validation of coded diagnoses. Purpose: To evaluate whether influenza vaccine is associated with GBS. Methods: Controlled observational study using national data from the Medicare program, which ensures a predominantly elderly population. People included had a Medicare claim for influenza vaccination during September-December in 2000 or 2001. Medical records were reviewed to classify definite, probable, or possible GBS (or not a case) using a standardized case definition. In a risk interval design, the incidence rate of GBS during Weeks 0-6 after vaccination (exposed period) was compared to Weeks 9-14 after vaccination (comparison period). Data collection occurred during 2003-2007, and analysis was conducted during 2007-2009. Results: Primary analysis included 22.2 million vaccinees, among whom 164 definite or probable GBS cases with onset during Weeks 0-6 or 9-14 were identified. The incidence rate ratio (IRR [95% CIs]) based on the GBS rate in the vaccine-exposed versus comparison periods, was 1.04 (0.76, 1.43) for combined years; 0.86 (0.52, 1.41) among people vaccinated in 2000; and 1.21 (0.79, 1.86) among people vaccinated in 2001. Secondary analysis additionally included 74 possible GBS cases; results were similar. Conclusions: Overall, the results do not support an association between influenza vaccine receipt and GBS among the elderly for the years studied (2000-2001 and 2001-2002 formulations). (Am J Prev Med 2010;39(4):296-304) Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine
引用
收藏
页码:296 / 304
页数:9
相关论文
共 40 条
[31]   The Guillain-Barre syndrome and the 1993 and 1993-1994 influenza vaccines [J].
Lasky, T ;
Terracciano, GJ ;
Magder, L ;
Koski, CL ;
Ballesteros, M ;
Nash, D ;
Clark, S ;
Haber, P ;
Stolley, PD ;
Schonberger, LB ;
Chen, RT .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (25) :1797-1802
[32]   Guillain-Barre syndrome in northwest Greece [J].
Markoula, S. ;
Giannopoulos, S. ;
Sarmas, I. ;
Tzavidi, S. ;
Kyritsis, A. P. ;
Lagos, G. .
ACTA NEUROLOGICA SCANDINAVICA, 2007, 115 (03) :167-173
[33]   Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barre' syndrome [J].
Odaka, M ;
Yuki, N ;
Hirata, K .
JOURNAL OF NEUROLOGY, 2003, 250 (08) :913-916
[34]  
Ravasio A, 1997, NEUROLOGY, V48, P214
[35]   Distinguishing acuteonset CIDP from Guillain-Barre syndrome with treatment related fluctuations [J].
Ruts, L ;
van Koningsveld, R ;
van Doorn, PA .
NEUROLOGY, 2005, 65 (01) :138-140
[36]  
Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1
[37]   REASSESSMENT OF THE ASSOCIATION BETWEEN GUILLAIN-BARRE-SYNDROME AND RECEIPT OF SWINE INFLUENZA VACCINE IN 1976-1977 - RESULTS OF A 2-STATE STUDY [J].
SAFRANEK, TJ ;
LAWRENCE, DN ;
KURLAND, LT ;
CULVER, DH ;
WIEDERHOLT, WC ;
HAYNER, NS ;
OSTERHOLM, MT ;
OBRIEN, P ;
HUGHES, JM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (09) :940-951
[38]   GUILLAIN-BARRE-SYNDROME FOLLOWING VACCINATION IN THE NATIONAL-INFLUENZA-IMMUNIZATION-PROGRAM, UNITED-STATES, 1976-1977 [J].
SCHONBERGER, LB ;
BREGMAN, DJ ;
SULLIVANBOLYAI, JZ ;
KEENLYSIDE, RA ;
ZIEGLER, DW ;
RETAILLIAU, HF ;
EDDINS, DL ;
BRYAN, JA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1979, 110 (02) :105-123
[39]   Uiniversal influenza vaccination in the United States: Are we ready? Report of a meeting [J].
Schwartz, Benjamin ;
Hinman, Alan ;
Abramson, Jon ;
Strikas, Raymond A. ;
Allred, Norma ;
Uyeki, Timothy ;
Orenstein, Walter .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 :S147-S154
[40]   Diagnostic and classification criteria for the Guillain-Barre syndrome [J].
Van der Meché, FGA ;
Van Doorn, PA ;
Meulstee, J ;
Jennekens, FGI .
EUROPEAN NEUROLOGY, 2001, 45 (03) :133-139